Branded Ingredients
Proprietary liposomal systems, developed, controlled and supplied with defined commercial provenance.
GMPriority Pharma develops and supports branded ingredient collaborations, where liposomal systems are supplied under licence or structured exclusivity agreements.
These partnerships are designed to enable differentiated in-market positioning, while retaining manufacturing control and technical oversight.
Structured ingredient partnerships
Branded ingredient partnerships are structured to be:
- Developed exclusively for a single partner
- Supplied under defined licensing frameworks
- Positioned with controlled provenance
- Supported by structured technical documentation
Where exclusivity applies, agreements define territorial scope, application boundaries and supply continuity.
Technical & Manufacturing Integration
Branded ingredients are manufactured within GMP-aligned, FSSC ISO 22000-accredited facilities.
Each ingredient format is supported by:
- Defined production parameters
- Controlled batch manufacture
- Structural consistency across supply
- In-house analytical verification
This ensures differentiation is engineered into the system, not applied through branding.
How branded ingredients are developed
Branded ingredients are developed through a deliberate, collaborative process balancing scientific design with commercial clarity.
Some systems are built around a single, well-characterised active. Others are intentionally engineered as multi-ingredient liposomal systems, combining actives that are rarely formulated together due to differences in stability, solubility or behaviour.
This reflects a core GMPriority Pharma capability:
⇒ integrating complex actives into coherent, manufacturable liposomal systems.
Designed for Long-Term Commercial Value
Branded ingredient partnerships are structured to support:
- Controlled market positioning
- Clear differentiation from generic alternatives
- Stable long-term supply
- Ongoing technical support
These partnerships are designed for organisations seeking defensible, long-term ingredient strategies within liposomal formats.
Where branded ingredients create value
⊕ Brands seeking proprietary, defensible ingredient positioning
⊕ Ingredient companies commercialising differentiated formats
⊕ Partners requiring exclusivity within defined application areas
⊕ Organisations building long-term IP within liposomal delivery systems
Case Study:
SAIFColl3®
Branded Liposomal Collagen
SAIFColl3® represents the next generation of collagen supplementation.
A liposomal collagen tripeptide (CTP) engineered for maximum absorption, rapid bioavailability and clinically relevant benefits across skin, joints, bones and connective tissues.
Supplied under controlled commercial agreements, SAIFColl3® demonstrates how proprietary liposomal ingredients are positioned with:
- Defined manufacturing provenance
- Structured supply continuity
- Technical documentation support
- Controlled market differentiation
Production is managed within GMP-aligned, FSSC ISO 22000-accredited facilities, securing repeatable batch output and long-term supply stability.
Available under NDA for qualified partners
Contact us
Ask us about branded ingredient opportunities.
